Cargando…

Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience

BACKGROUND AND OBJECTIVE: Here, we present real-world data on the incidence and risk factors of acute exacerbation (AE) in patients with chronic fibrotic interstitial pneumonia (CFIP) treated with antifibrotic agents, which has been previously poorly documented. METHODS: We retrospectively examined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawamura, Kodai, Ichikado, Kazuya, Ichiyasu, Hidenori, Anan, Keisuke, Yasuda, Yuko, Suga, Moritaka, Sakagami, Takuro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593518/ https://www.ncbi.nlm.nih.gov/pubmed/31238929 http://dx.doi.org/10.1186/s12890-019-0880-0

Ejemplares similares

Monocyte count and the risk for acute exacerbation of fibrosing interstitial lung disease: A retrospective cohort study
por: Kawamura, Kodai, et al.
Publicado: (2020)

Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study
por: Kawamura, Kodai, et al.
Publicado: (2017)

A Scoring System with High-Resolution Computed Tomography to Predict Drug-Associated Acute Respiratory Distress Syndrome: Development and Internal Validation
por: Anan, Keisuke, et al.
Publicado: (2019)

The ROX index (Index combining the respiratory rate with oxygenation) is a prognostic factor for acute respiratory distress syndrome
por: Nishiyama, Kenta, et al.
Publicado: (2023)

Hermansky–Pudlak syndrome type 4 with interstitial pneumonia
por: Sakata, Yoshihiko, et al.
Publicado: (2013)

Clinical phenotypes from fatal cases of acute respiratory distress syndrome caused by pneumonia
por: Ichikado, Kazuya, et al.
Publicado: (2021)

An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J)
por: Ichikado, Kazuya, et al.
Publicado: (2023)

Clinical characteristics and prognosis of drug-associated acute respiratory distress syndrome compared with non-drug-associated acute respiratory distress syndrome: a single-centre retrospective study in Japan
por: Anan, Keisuke, et al.
Publicado: (2017)

Efficacy of azithromycin in sepsis-associated acute respiratory distress syndrome: a retrospective study and propensity score analysis
por: Kawamura, Kodai, et al.
Publicado: (2016)

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
por: Niitsu, Takayuki, et al.
Publicado: (2023)

The negative effect of initial high-dose methylprednisolone and tapering regimen for acute respiratory distress syndrome: a retrospective propensity matched cohort study
por: Takaki, Makoto, et al.
Publicado: (2017)

Multinodular lung infiltrate in a patient with lymphoma: metastasis, tuberculosis or other?
por: Anan, Keisuke, et al.
Publicado: (2017)

Dendriform Pulmonary Ossification
por: Anan, Keisuke, et al.
Publicado: (2018)

Alkaline phosphatase flare phenomenon following epidermal growth factor receptor-tyrosine kinase inhibitor treatment of non-small cell lung cancer: Report of a case and case review
por: Yasuda, Yuko, et al.
Publicado: (2014)

Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD
por: Shumar, John N., et al.
Publicado: (2021)

Comparisons between tumor burden and other prognostic factors that influence survival of patients with non‐small cell lung cancer treated with immune checkpoint inhibitors
por: Sakata, Yoshihiko, et al.
Publicado: (2019)

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2019)

Case report: continued treatment with alectinib is possible for patients with lung adenocarcinoma with drug-induced interstitial lung disease
por: Nitawaki, Tatsuya, et al.
Publicado: (2017)

Acute exacerbations of progressive-fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2018)

The effects of switching EGFR‐TKI treatments for non‐small cell lung cancer because of adverse events
por: Sakata, Yoshihiko, et al.
Publicado: (2018)

Interstitial Lung Disease in Adulthood Associated with Surfactant Protein C Gene Mutation in a Patient with a History of Lipoid Pneumonia in Infancy
por: Furukawa, Tsuguhiro, et al.
Publicado: (2023)

Fibroproliferative changes on high-resolution CT in the acute respiratory distress syndrome predict mortality and ventilator dependency: a prospective observational cohort study
por: Ichikado, Kazuya, et al.
Publicado: (2012)

Prognostic impact of pre-existing interstitial lung disease in non-HIV patients with Pneumocystis pneumonia
por: Hamada, Shohei, et al.
Publicado: (2020)

Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases
por: Salonen, Johanna, et al.
Publicado: (2020)

A cohort study of mortality predictors in patients with acute exacerbation of chronic fibrosing interstitial pneumonia
por: Usui, Yutaka, et al.
Publicado: (2013)

COVID-19 and acute exacerbation of interstitial lung disease
por: Kondoh, Yasuhiro, et al.
Publicado: (2021)

Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis
por: Anan, Keisuke, et al.
Publicado: (2022)

Correction: Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis
por: Anan, Keisuke, et al.
Publicado: (2023)

Epimorphin expression in interstitial pneumonia
por: Terasaki, Yasuhiro, et al.
Publicado: (2005)

Serum autotaxin levels in chronic disease and acute exacerbation of fibrosing interstitial lung disease
por: Isshiki, Takuma, et al.
Publicado: (2022)

(18)F‐FDG uptake in accessory respiratory muscles shows the respiratory effort of patients with pleuroparenchymal fibroelastosis
por: Okabayashi, Hiroko, et al.
Publicado: (2022)

Biomarkers of Fibroproliferative Healing in Fibrosing Idiopathic Interstitial Pneumonias
por: Vasakova, Martina, et al.
Publicado: (2012)

Progression of fibrosing interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020)

Management of Fibrosing Interstitial Lung Diseases
por: Maher, Toby M., et al.
Publicado: (2019)

A Case of Orbital Metastasis as Disease Progression of Anaplastic Lymphoma Kinase-Positive Lung Cancer Treated with Crizotinib
por: Sakata, Yoshihiko, et al.
Publicado: (2015)

Acute Exacerbation of Idiopathic Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma after Transcatheter Arterial Therapy Using Miriplatin
por: Kakiuchi, Yosuke, et al.
Publicado: (2019)

Impact of lymphocyte differential count > 15% in BALF on the mortality of patients with acute exacerbation of chronic fibrosing idiopathic interstitial pneumonia
por: Takei, Reoto, et al.
Publicado: (2017)

Association of serum monomeric periostin level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
por: Shimizu, Hiroshige, et al.
Publicado: (2021)

Effect of nintedanib on acute exacerbations of fibrosing interstitial lung diseases: a national database study in Japan
por: Urushiyama, Hirokazu, et al.
Publicado: (2022)

Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias
por: Hoeper, Marius M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kstbclp0nr23g0m00f54h4q0j4